T
here is abundant evidence of a discontinuity ("jump") in the atrioventricular node (AVN) conduction (A 1 A 2 /A 2 H 2 ) curves that do not produce AV nodal reentrant tachycardia (AVNRT) and in AVNRT not associated with such jumps. [1] [2] [3] Dual inputs "attached" to corresponding functionally different nodal pathways can explain the occurrence of sudden jumps in the AVN conduction curve. 4 -6 Using single atrial extrastimulation (A 1 A 2 ), others 2, 7 have suggested that smooth A 1 A 2 /A 2 H 2 curves might consist of 2 distinct components representing both fast and slow pathways, even when typical discontinuity is absent. Failure to show a discontinuous A 1 A 2 /A 2 H 2 curve in AVNRT may be related to a "less than a jump" difference between slow pathway and fast pathway conduction. 1,3,8 -10 Sheahan et al 2 showed that conventional slow pathway ablation in patients with otherwise typical AVNRT without evidence of dual pathways results in a clinical cure and loss of the terminal portion of the A 1 A 2 /A 2 H 2 curve. However, characterization of AVNRT with a continuous A 1 A 2 /A 2 H 2 curve by double atrial extrastimulation (A 1 A 2 A 3 ) has never been systematically studied. Thus, the purpose of the present study was to define the therapeutic end points for successful slow pathway ablation in patients with a continuous AVN conduction curve by A 1 A 2 A 3 .
Methods

Patients
The study population consisted of 2 groups of patients. All patients underwent electrophysiological study and radiofrequency ablation at Chang Gung Memorial Hospital for typical AVNRT. Group 1 included 33 patients without clear-cut discontinuity of the AVN conduction curves defined by single atrial extrastimulation. Group 2 included 103 patients with discontinuous AVN conduction curves.
Electrophysiological Study
Informed consent for the study and ablation was obtained from all patients. Each patient was studied in the postabsorptive state without sedation. All antiarrhythmic drugs were discontinued for at least 5 half-lives before the study. 11, 12 Multipolar electrode catheters were positioned in the coronary sinus, high right atrium, His bundle, and right ventricular apex. The decapolar electrode catheter in the coronary sinus had its most proximal electrode pair positioned just inside the ostium. Intracardiac electrograms from the high right atrium, His bundle, and coronary sinus electrodes, along with ECG leads I, aVF, and V 1 , were continuously recorded (EP Laboratory, Biomedical Instrumentation, Inc and Catheterization2000 Crossover System, Gould, Inc). Programmed electrical stimulation (model DTU-215, Bloom Associates, Ltd) was delivered by use of 2-ms rectangular impulses at twice the late diastolic pacing threshold. All intracardiac electrograms were bandpass-filtered between 40 and 500 Hz. Briefly, the stimulation protocol consisted of high right atrial and right ventricular incremental pacing to block and extrastimulus testing with at least 2 driven cycle lengths (usually 600 and 400 ms). The initiation of typical AVNRT was generally associated with a discontinuous A 1 A 2 /A 2 H 2 curve. 6, 11, 12 A 1 A 2 A 3 was then performed by use of predetermined fast pathway-conducted A 2 (A 1 A 2 usually at 50 to 100 ms greater than the effective refractory period [ERP] of AVN or fast pathway with an A 2 H 2 Ͻ180 ms), namely fast pathway-coupled A 1 A 2 A 3 in both groups. We always checked the atrial-His bundle (AH) during induction of single AVN echo or induction and maintenance of the AVNRT to determine that the predefined A 2 and thus A 2 H 2 did not fall into the slow pathway range. The first of 2 premature beats was called the conditioning beat. The test beats, labeled A 3 , were introduced with progressively shorter A 2 A 3 , starting from 600 ms in steps of 10 ms, until the ERP of AVN or the atrium was reached 8 in each stimulating cycle. The A 2 A 3 /A 3 H 3 curve was then constructed. The examination of a given patient was performed with stimulation from the same pacing sites during different protocols.
Endocardial Mapping and Radiofrequency Ablation
All patients underwent ablation through the posterior approach. 6, [13] [14] [15] [16] [17] Three zones within the triangle of Koch along the tricuspid annulus were arbitrarily defined, including the anterior third, middle third, and posterior third regions between the His-bundle recording site and coronary sinus ostium. These regions were further divided into 2 subsections, the anterior-2 (A2) and anterior-1 (A1), middle-2 (M2) and middle-1 (M1), and posterior-2 (P2) and posterior-1 (P1), respectively. The orifice of the coronary sinus was demarcated by coronary sinus venography. A 7F quadripolar deflectable catheter (Mansfield Scientific) with a 4-mm tip electrode was used for mapping and ablation. A radiofrequency generator (RFG-3C, Radionics) was used to deliver energy at a power setting of 30 W for 30 seconds during each attempt. Application of energy was interrupted if junctional tachycardia did not appear within 10 seconds or if impedance rise, PR prolongation, or AVN block occurred. Lesions were basically anatomically guided and directed to the posterior, then the middle, and finally to the anterior area if necessary. The presumed ablation site was considered optimal if the bipolar electrograms recorded from the distal electrodes showed an atrial-to-ventricular electrogram amplitude ratio of 0.1 to 0.5 (usually Յ0.25). 6, 11, 13 After each application of energy, the presence or absence of slow pathway conduction and inducibility of AVNRT was assessed with programmed electrical stimulation.
The end point of a successful ablation was defined as noninducibility of AVNRT with isoproterenol infusion (at graded doses from 1 to 4 g/min IV) and/or atropine (0.01 to 0.02 mg/kg IV), even though the residual anterograde slow pathway might be present 6, 11, 13, 14 without or with a single AVN echo.
Postablation Electrophysiological Evaluation
All patients underwent repeat testing with single and double atrial extrastimuli before and during the administration of isoproterenol and/or atropine, 30 minutes after successful ablation, and during a later follow-up study at 3 months. All parameters were measured on the 3 occasions. Each time, measurements were done during the baseline states.
Definitions
Dual pathway physiology was defined as discontinuous AVN conduction curves during single atrial extrastimulation. It was characterized by a Ն50-ms jump in A 2 H 2 at a critical range of A 1 A 2 coupling intervals (10-ms decrease) during 2 different paced cycle lengths, 1, 11, 14 resulting in a discontinuity between the curve to the right of the jump in A 2 H 2 (fast pathway) and the portion with the jump (slow pathway). The ERP of the fast pathway was defined on the basis of discontinuous A 1 A 2 /A 2 H 2 curves. The ERP of the AVN was defined as the longest A 1 A 2 that failed to result in an H 1 -H 2 response. In patients with discontinuous A 1 A 2 /A 2 H 2 curves, the AVN ERP therefore reflects the ERP of the slow pathway; in those with continuous A 1 A 2 /A 2 H 2 curves, the AVN ERP refers to the shortest ERP. For each patient, the driven cycle lengths and the coupling intervals of the A 1 A 2 at which ERP measurements and A 2 A 3 /A 3 H 3 curves were obtained before ablation were matched and repeated after ablation. The A 2 H 2 max and A 3 H 3 max were defined as the maximal AH measured during A 1 A 2 and A 1 A 2 A 3 , respectively.
Statistical Analysis
Data were expressed as meanϮSD. A repeated-measures analysis was applied to compare the continuous variables among 3 consecutive data points before and after ablation. 
Results
Baseline
Effects of Ablation With the Posterior Approach on AVN Conduction in Group 1
Sustained AVNRT of the slow-fast form was induced in all patients before ablation. Isoproterenol infusion was required for its initiation in 12 patients (36%). Definite evidence of dual AVN physiology as shown by discontinuity of the A 1 A 2 /A 2 H 2 curve was not present in all patients before ablation.
The effects of ablation with the posterior approach on the refractory period and conduction properties of the AVN are shown in the (Figures 2 and 3) . Successful ablation resulted in the loss or marked diminution ( Figures 2B and 3B ) of the discontinuous A 2 A 3 /A 3 H 3 curve on the left in the former. A lack of discontinuity in the A 2 A 3 / 
Effects of Slow Pathway Ablation on AVN Conduction in Group 2
Sustained typical AVNRT was induced in all patients before ablation. Isoproterenol infusion was required for the induction in 44 patients (43%). Definite evidence of dual AVN physiology with discontinuous curves was demonstrated during both A 1 A 2 and A 1 A 2 A 3 in all patients before ablation.
The effects of slow pathway ablation on the refractory period and conduction properties of the AVN are shown in the 
Comparison of Groups 1 and 2
Before ablation, the sinus cycle length, the anterograde AVNWCL, and the A 2 H 2 max and A 3 H 3 max showed significant differences (PϽ0.05) between groups 1 and 2 ( Figure 1 ). Immediately after ablation, the sinus cycle length, AVN ERP, and AVNWCL showed significant differences (PϽ0.05) between the 2 groups.
Late Electrophysiological Follow-Up at 3 Months or Later
At late follow-up, the sinus cycle length, anterograde AVN-WCL, and AVN ERP increased from immediate postablation studies in a similar trend ( Figure 5 ) in both groups (Table) . In group 2, the ERP of the slow pathway increased immediately after ablation (274Ϯ45 versus 316Ϯ72 ms, PϽ0.0001) and increased further (368Ϯ78 ms, PϽ0.0001) at 3-month follow-up. Conversely, the ERP of the fast pathway in group 2 shortened (366Ϯ82 versus 339Ϯ73 ms, PϽ0.0001) immediately after ablation but increased in the long run (406Ϯ100 ms, PϽ0.0001) during the late follow-up.
The baseline AH, retrograde AVNWCL, A 2 H 2 max, and A 3 H 3 max remained unchanged between the 2 postablation studies in both groups.
As a whole, there were significant differences in the tendency of the series of changes in the electrophysiological variables, including the sinus cycle length, AVN ERP, anterograde AVNWCL, and A 2 H 2 max among 3 measurements between the 2 groups (PϽ0.05, adjusted by age and time).
Discussion Major Findings
In those with discontinuous AVN function curves during A 1 A 2 (group 2), the anterograde AVN ERP increased. The ERP of the residual slow pathway increased, whereas that of 
Electrophysiological Characteristics of the AV Node in Patients With and Without Discontinuous AV Conduction Curves Before and After Ablation
Mechanisms of Failure to Demonstrate a Distinct Discontinuity
Several potential mechanisms may account for the failure to demonstrate distinct discontinuity in the AVN conduction (A 1 A 2 /A 2 H 2 ) curves in otherwise typical AVNRT. Differences in the refractory periods and conduction properties between the fast and slow pathways may not be sufficiently distinct at baseline study to yield discontinuity in the A 1 A 2 / A 2 H 2 curve. 1, 2, 7 It is well known in the electrophysiology laboratory that discontinuous AVN conduction curves may become continuous during isoproterenol infusion, 3, [15] [16] [17] [18] [19] [20] because the refractory period of the fast pathway could be abbreviated to the extent that the slow pathway conduction could not be achieved with single or even double atrial extrastimuli or with incremental atrial pacing.
In group 1 patients, A 1 A 2 A 3 failed to expose the discontinuity of the A 2 A 3 /A 3 H 3 curve in a minority of patients. Successful ablation with the posterior approach in these patients resulted in the loss of the tail of the A 2 A 3 /A 3 H 3 curve representing the slow pathway. The observation that successful ablation did not produce any changes in the A 1 A 2 /A 2 H 2 format is an important and very instructive finding. It indicates that the slow pathway, although present before the ablation, was not detectable in the above format. Conversely, the A 2 A 3 /A 3 H 3 format, although not always manifesting the slow pathway by means of a jump, allowed the conclusion that the ablation did affect the slow pathway portion of the conduction curve. However, one cannot conclude from this Figure 1 . A, Anterograde AVNWCL for 2 groups. AVNWCL remained unchanged after ablation but increased at 3-month follow-up (group 1, 343Ϯ59 vs 378Ϯ90 ms; group 2, 381Ϯ77 vs 460Ϯ108 ms) in both groups. B, ERPs of anterograde AVN for 2 groups. ERP of AVN increased (274Ϯ45 vs 321Ϯ67 ms) after ablation in group 2 but was unchanged in group 1. At 3-month follow-up, ERP of AVN increased from immediate postablation studies in a similar trend in both groups (277Ϯ47 vs 320Ϯ85 ms in group 1; 321Ϯ67 vs 397Ϯ99 ms in group 2). C, A 2 H 2 max for 2 groups. A 2 H 2 max shortened markedly in group 2 (395Ϯ72 vs 221Ϯ78 ms) but showed little change in group 1 after ablation. A 2 H 2 max remained unchanged between immediate and late postablation studies in both groups. D, A 3 H 3 max markedly shortened not only in group 2 (419Ϯ104 vs 220Ϯ78 ms) but also in group 1 (375Ϯ81 vs 238Ϯ82 ms) after ablation. A 3 H 3 max remained unchanged between immediate and late postablation studies in both groups. *PϽ0.003, preablation vs late followup, postablation vs late follow-up. **PϽ0.0001, preablation vs postablation vs late follow-up. †PϽ0.003, preablation vs postablation, preablation vs late follow-up.
result that the ablation eliminated the slow pathway. It is quite logical to say that the ablation may have now rendered the slow pathway not detectable in the A 2 A 3 /A 3 H 3 format as well. In other words, the elimination of the AVNRT may not necessarily be equaled with elimination of the slow pathway; thus the dual pathway electrophysiology. These findings suggest that the smooth A 2 A 3 /A 3 H 3 curve might in fact consist of 2 distinct components, which may be linked to one or the other pathway, respectively. Atrial burst pacing and isoproterenol were required for the initiation of AVNRT in 3 of these patients. One other patient required A 1 A 2 A 3 to initiate AVNRT. The slow pathway conduction could be achieved in these circumstances to set up for reentry to occur. However, it was difficult to draw any conclusions on the electrophysiological characteristics of the AVN in such a small number of patients.
The anterograde AVN ERP, AVNWCL, and A 2 H 2 max remained unchanged in group 1. A 3 H 3 max was the only electrophysiological parameter that shortened significantly after successful ablation. To facilitate the ablation procedure, it may be much easier to use A 1 A 2 A 3 as defined in the report to establish an acceptable therapeutic end point, ie, A 3 H 3 max may be a better indicator than A 2 H 2 max in determining and confirming the success of the ablation.
Lessons Learned From Ablation
This study further supports the hypothesis that use of double atrial extrastimulation could reveal distinct discontinuity in the A 2 A 3 /A 3 H 3 curves in most patients with smooth A 1 A 2 /A 2 H 2 curves. Of note, loss of the terminal portion of the A 2 A 3 /A 3 H 3 curves (to the left of the discontinuity) representing slow pathway conduction occurred after the elimination of the AVNRT, leaving a continuous A 2 A 3 /A 3 H 3 curve. At times, the "slow pathway" zone was only modified, leaving a discontinuous A 2 A 3 / A 3 H 3 curve after elimination of the inducibility of AVNRT. Nonetheless, A 3 H 3 max always shortened in a significant magnitude. In those who still failed to show discontinuous A 2 A 3 /A 3 H 3 curves during A 1 A 2 A 3 , successful ablation always resulted in the loss or marked diminution of the terminal portion of the curve on the left, which may be linked to the slow pathway component.
A 3 H 3 max decreased in a parallel fashion after successful ablation in both groups. Both A 2 H 2 max and A 3 H 3 max were shorter in those with smooth A 1 A 2 /A 2 H 2 curves, implying a "less decremental" slow pathway, as suggested by previous studies. 2, 7 The data suggest that the use of the A 2 could increase the difference in conduction time of the fast and slow pathways, although the A 2 A 3 /A 3 H 3 curves remained continuous in some patients. 
Limitations
In this study, we did not use autonomic blockade to control for autonomic tone. However, autonomic blockade has been shown not to affect the observed changes in postablation refractoriness. 19 In our A 1 A 2 A 3 study, it might be true that neither "A 1 A 2 usually at 50 to 100 ms greater than the ERP of AVN or fast pathway" nor "A 2 H 2 Ͻ180 ms" is an indicator of fast pathway conduction. Although we always checked the AH during induction of single AVN echo, induction and maintenance of the AVNRT to determine that the predefined A 2 and thus A 2 H 2 did not fall into the slow pathway range. In fact, the predefined A 2 H 2 was most often Ͻ150 ms. However, this would not guarantee that slow pathway-coupled A 2 did not occur.
Another potential limitation is the choice of the A 2 , which may be arbitrary in such a way that A 3 H 3 max may not really be the longest attainable interval during A 1 A 2 A 3 . It is also likely that the longest attainable AH interval, AHmax, could be obtained during atrial burst pacing instead of atrial extrastimulation.
We did not routinely use a third drive cycle length to expose discontinuity of the A 1 A 2 /A 2 H 2 and/or A 2 A 3 /A 3 H 3 curves. It is possible that use of various atrial sites, 16 3 or more extrastimuli, or pharmacological intervention could have revealed discontinuity in some of the patients with smooth AVN curves.
Clinical Implications
It has been well established that total elimination or modification of the slow pathway, to the extent that repetitive AVN reentry cannot be induced, is an acceptable therapeutic end point that portends a good prognosis. 6, 13, [21] [22] [23] [24] However, the end point is less distinct when the AVN conduction curves do not demonstrate a classic jump at the transition from the fast to slow pathway conduction. After successful ablation, A 2 H 2 max might shorten significantly in group 1 patients, as demonstrated by Tai et al 7 and Sheahan et al. 2 In this study, however, the postablation A 2 H 2 max did reveal a trend to decrease, although the difference was noted to be statistically insignificant. The anterograde AVN ERP and AVNWCL also remained unchanged after ablation in this group. Because A 3 H 3 max is the only electrophysiological parameter that shortened in a greater magnitude, it may be shown that A 3 H 3 max is a good (if not better) indicator compared with A 2 H 2 max in portending a successful outcome for ablation. It is hoped that this approach will facilitate the ablation procedure in patients with smooth A 1 A 2 /A 2 H 2 curves who otherwise have typical AVNRT. Finally, the study suggests that a decrease of Ն100 to 150 ms in A 3 H 3 max may be indicative of clinical success. This merits further study in a large patient population.
